These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2142057)

  • 1. Isoform patterns of apolipoprotein E in diabetes mellitus.
    Black SC; Hewett S; Kotubi Y; Brunt RV; Reckless JP
    Diabet Med; 1990 Jul; 7(6):532-9. PubMed ID: 2142057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE-2/E-3 ratio of very low density lipoprotein in diabetes mellitus.
    Sano R; Abe R; Oikawa S; Fujii Y; Toyota T
    Tohoku J Exp Med; 1985 Jun; 146(2):131-6. PubMed ID: 4024089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E polymorphism affects the response to pravastatin on plasma apolipoproteins in diabetic patients.
    Watanabe J; Kobayashi K; Umeda F; Yamauchi T; Mimura K; Nakashima N; Masakado M; Hiramatsu S; Nawata H
    Diabetes Res Clin Pract; 1993 Apr; 20(1):21-7. PubMed ID: 8344125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoelectric focusing of apolipoproteins in immobilized pH gradients: improved determination of apolipoprotein E phenotypes.
    Baumstark MW; Berg A; Halle M; Keul J
    Electrophoresis; 1988 Sep; 9(9):576-9. PubMed ID: 3243253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese.
    Sano R; Abe R; Oikawa S; Fujii Y; Hori S; Suzuki N; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Mar; 154(3):297-303. PubMed ID: 3376106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
    Kobayashi T; Homma Y
    J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism and hyperlipidemia.
    Assmann G; Schmitz G; Menzel HJ; Schulte H
    Clin Chem; 1984 May; 30(5):641-3. PubMed ID: 6713624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
    Horita K; Eto M; Makino I
    Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution of the apolipoprotein-E and -E-complexes in lipoproteins of human serum with the apolipoprotein-E4/E3 phenotype].
    Hidaka H; Tozuka M; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Rinsho Byori; 1997 Dec; 45(12):1172-6. PubMed ID: 9437899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.
    Saito M; Eto M; Kaku K
    Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
    Janus ED; Grant S; Lintott CJ; Wardell MR
    Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
    Laakso M; Kesäniemi A; Kervinen K; Jauhiainen M; Pyörälä K
    BMJ; 1991 Nov; 303(6811):1159-62. PubMed ID: 1747611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents.
    Salo MK; Rantanen R; Huupponen T; Lehtimäki T; Jokela H
    Eur J Pediatr; 1993 Jul; 152(7):564-8. PubMed ID: 8354314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E variation in patients with hyperlipidaemia: DNA and protein phenotyping.
    McCormick SP; Fellowes AP; Brennan SO; George PM
    N Z Med J; 1989 Oct; 102(877):534-6. PubMed ID: 2797589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.
    Eto M; Watanabe K; Ishii K
    Clin Chim Acta; 1985 Jun; 149(1):21-8. PubMed ID: 4028432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.